New treatment options offer hope for patients with non-small cell lung cancer

More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumour cells, with less need for chemotherapy, following results of multiple landmark clinical trials reported for the first time in late-breaking presentations at the ESMO Congress 2023 (1-7).

Related Keywords

Tbilisi ,Georgia General ,Georgia , ,Fribourg ,Switzerland ,Elene Mariamidze ,Alessandra Curioni Fontecedro ,Danielle Ellis ,University Of Fribourg ,Todua Clinic ,Cancer ,Cancer Treatment ,Lung Cancer ,Research ,Ntibody ,Rain ,Fell ,Chemotherapy ,Drugs ,Immunotherapy ,Utation ,Non Small Cell Lung Cancer ,Ncology ,Small Cell Lung Cancer ,Surgery ,